DESIGN AND CHARACTERISATION OF ORO-DISPERSIBLE FILM OF CINNARIZINE FOR THE TREATMENT OF MOTION SICKNESS

  • Unique Paper ID: 167269
  • Volume: 11
  • Issue: 3
  • PageNo: 708-711
  • Abstract:
  • Motion sickness (MS) is a common condition triggered by various forms of transportation, causing symptoms such as nausea, vomiting, and dizziness. Oro-dispersible films (ODFs) represent a novel drug delivery system designed for ease of administration, rapid onset of action, and improved patient compliance. This study aims to design, characterize, and assess the in vivo efficacy of an ODF of cinnarizine, a drug commonly used to treat motion sickness. The research focuses on formulating a film that dissolves quickly in the oral cavity, delivering the active pharmaceutical ingredient efficiently, with an emphasis on stability, scalability, and patient-centered outcomes.

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{167269,
        author = {Amar G. Mundhe and Sainath N. Ingole and Ajinkya A. Purbe and Rupal k. Deshmukh and Mahendra c. Gunde},
        title = {DESIGN AND CHARACTERISATION OF ORO-DISPERSIBLE FILM OF CINNARIZINE FOR THE TREATMENT OF MOTION SICKNESS},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {3},
        pages = {708-711},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=167269},
        abstract = {Motion sickness (MS) is a common condition triggered by various forms of transportation, causing symptoms such as nausea, vomiting, and dizziness. Oro-dispersible films (ODFs) represent a novel drug delivery system designed for ease of administration, rapid onset of action, and improved patient compliance. This study aims to design, characterize, and assess the in vivo efficacy of an ODF of cinnarizine, a drug commonly used to treat motion sickness. The research focuses on formulating a film that dissolves quickly in the oral cavity, delivering the active pharmaceutical ingredient efficiently, with an emphasis on stability, scalability, and patient-centered outcomes.},
        keywords = {},
        month = {August},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 3
  • PageNo: 708-711

DESIGN AND CHARACTERISATION OF ORO-DISPERSIBLE FILM OF CINNARIZINE FOR THE TREATMENT OF MOTION SICKNESS

Related Articles